File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Overall Survival Benefits of First-Line Treatments for Asian Patients With Advanced EGFR-Mutated NSCLC Harboring L858R Mutation: A Systematic Review and Network Meta-Analysis

TitleOverall Survival Benefits of First-Line Treatments for Asian Patients With Advanced EGFR-Mutated NSCLC Harboring L858R Mutation: A Systematic Review and Network Meta-Analysis
Authors
Issue Date2022
Citation
JTO Clinical and Research Reports, 2022, v. 3, p. 100322 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/316876

 

DC FieldValueLanguage
dc.contributor.authorChan, SK-
dc.contributor.authorChoi, CW-
dc.contributor.authorLee, VHF-
dc.date.accessioned2022-09-16T07:24:54Z-
dc.date.available2022-09-16T07:24:54Z-
dc.date.issued2022-
dc.identifier.citationJTO Clinical and Research Reports, 2022, v. 3, p. 100322-
dc.identifier.urihttp://hdl.handle.net/10722/316876-
dc.languageeng-
dc.relation.ispartofJTO Clinical and Research Reports-
dc.titleOverall Survival Benefits of First-Line Treatments for Asian Patients With Advanced EGFR-Mutated NSCLC Harboring L858R Mutation: A Systematic Review and Network Meta-Analysis-
dc.typeArticle-
dc.identifier.emailChan, SK: kskchan@HKUCC-COM.hku.hk-
dc.identifier.emailChoi, CW: hcchoi@hku.hk-
dc.identifier.emailLee, VHF: vhflee@hku.hk-
dc.identifier.authorityChoi, CW=rp02815-
dc.identifier.authorityLee, VHF=rp00264-
dc.identifier.doi10.1016/j.jtocrr.2022.100322-
dc.identifier.hkuros336888-
dc.identifier.volume3-
dc.identifier.spage100322-
dc.identifier.epage100322-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats